Prospective Cohort Study in Alport Syndrome Patients Under Standard Therapy
In patients with AS receiving standard of care, rapid decline in kidney function strongly correlates with UACR and AEs related to the underlying medical condition are rare. Both findings enrich the design of future interventional trials.
Authors
- Yuqian Shen
- Michelle N. Rheault (ORCID: https://orcid.org/0000-0003-2494-3970)
- Clifford E. Kashtan (ORCID: https://orcid.org/0000-0002-0839-4310)
- Oliver Groß (ORCID: https://orcid.org/0000-0002-8390-8852)
- Bertrand Knebelmann (ORCID: https://orcid.org/0000-0002-8115-7303)
- Julie Lin (ORCID: https://orcid.org/0000-0002-0932-6053)
- James F. Simon
- Shiguang Liu (ORCID: https://orcid.org/0000-0003-0732-5230)
- Qi Zhang (ORCID: https://orcid.org/0009-0004-1304-1773)
- Ali Hariri
Institutions
- Cleveland Clinic (US)
- Université Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Sanofi (United States) (US)
- Nephrologisches Zentrum Goettingen (DE)
- University of Minnesota Children's Hospital (US)
Publication Details
- Journal
- Kidney International Reports
- Published
- 2025-03-06
- DOI
- https://doi.org/10.1016/j.ekir.2025.02.036
- Citations
- 3
- Primary Topic
- Cell Adhesion Molecules Research
- Type
- article
- Field-Weighted Citation Impact
- 4.87
Funders
- Sanofi